Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06135363
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 45
Testing effectiveness (Phase 2)Ended earlyNCT03287414
What this trial is testing

Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)UnknownNCT05424887
What this trial is testing

Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai Ark Biopharmaceutical Co., Ltd. 105
Large-scale testing (Phase 3)Ended earlyNCT00879229
What this trial is testing

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Gilead Sciences 40
Post-approval studies (Phase 4)WithdrawnNCT00625469
What this trial is testing

Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Rajan Saggar
Testing effectiveness (Phase 2)Study completedNCT06764862
What this trial is testing

Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Haisco Pharmaceutical Group Co., Ltd. 186
Testing effectiveness (Phase 2)Study completedNCT00463983
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide

Who this might be right for
Idiopathic Pulmonary Fibrosis
Institut National de la Santé Et de la Recherche Médicale, France 25
Not applicableNot Yet RecruitingNCT07162870
What this trial is testing

Idiopathic Pulmonary Fibrosis Cohort of TCM

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Henan University of Traditional Chinese Medicine 1,000
Not applicableUnknownNCT02885961
What this trial is testing

The Coagulation Cascade in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisIPFInterstitial Lung Disease
University College, London 12
Not applicableStudy completedNCT07178197
What this trial is testing

Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Sarcopenia
Mersin University 60
Not applicableLooking for participantsNCT00258570
What this trial is testing

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
University of Pittsburgh 2,000
Testing effectiveness (Phase 2)WithdrawnNCT01135199
What this trial is testing

Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Stanford University
Not applicableLooking for participantsNCT07790614
What this trial is testing

Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis

Who this might be right for
IPFILDInterstitial Lung Disease (ILD)+7 more
Istituto Clinico Humanitas 156
Early research (Phase 1)Study completedNCT03502902
What this trial is testing

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 55
Not applicableNot Yet RecruitingNCT06922916
What this trial is testing

Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study

Who this might be right for
COPDInterstitial PneumoniaBronchiectasis+6 more
Zhejiang University 250
Early research (Phase 1)Study completedNCT06569381
What this trial is testing

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 18
Not applicableStudy completedNCT03281200
What this trial is testing

Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 172
Early research (Phase 1)Study completedNCT01919827
What this trial is testing

Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Clinica Universidad de Navarra, Universidad de Navarra 17
Large-scale testing (Phase 3)Study completedNCT01366209
What this trial is testing

Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 555
Not applicableStudy completedNCT01071707
What this trial is testing

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 108
Next Page